Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
Clinical trial NCT03975036 · UNKNOWN
Trial details
- NCT number
- NCT03975036
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-08
- Primary completion
- 2020-06-08
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.